Last reviewed · How we verify

NCT05449613

Efficacy and Safety Evaluation of Acupoint Application in the Treatment of Knee Osteoarthritis Joint Pain

Status unknown Phase 3 Last updated 8 July 2022
What this trial tests

Phase 3 trial testing acupoint application in Knee Osteoarthritis in 120 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
1 October 2023
1 October 2024

Quick facts

Lead sponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment120
Start date1 October 2021
Primary completion1 October 2023
Estimated completion1 October 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Who can join

Adults 40 to 75, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy and safety of acupoint application of Traditional Chinese medicine in the treatment of KOA joint pain through a prospective, randomized, double-blind, placebo-controlled clinical study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Guang'anmen Hospital of China Academy of Chinese Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05449613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing